Analysis Article • May 01

Over the last 7 days, the Clinical Research and Equipment industry has remained flat. As for the longer term, the industry has declined 17% in the last year. Looking forward, earnings are forecast to grow by 19% annually.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 15 Jun 2026 | SEK 29.9b | SEK 14.6b | -SEK 871,304,353.00 | 34.5x | -34.3x | 2x |
| Wed, 13 May 2026 | SEK 28.8b | SEK 14.6b | -SEK 853,896,077.00 | 35.2x | -33.7x | 2x |
| Fri, 10 Apr 2026 | SEK 28.0b | SEK 14.6b | -SEK 971,664,077.00 | 32.8x | -28.8x | 1.9x |
| Sun, 08 Mar 2026 | SEK 27.7b | SEK 14.6b | -SEK 838,374,077.00 | 33.5x | -33x | 1.9x |
| Tue, 03 Feb 2026 | SEK 27.4b | SEK 14.9b | -SEK 744,515,427.00 | 42.2x | -36.8x | 1.8x |
| Thu, 01 Jan 2026 | SEK 31.4b | SEK 14.9b | -SEK 744,515,427.00 | 49.2x | -42.1x | 2.1x |
| Sat, 29 Nov 2025 | SEK 34.9b | SEK 14.9b | -SEK 744,515,427.00 | 58.5x | -46.9x | 2.3x |
| Mon, 27 Oct 2025 | SEK 38.2b | SEK 14.8b | SEK 117.3m | 56.2x | 325.9x | 2.6x |
| Wed, 24 Sep 2025 | SEK 35.8b | SEK 14.7b | SEK 61.3m | 58.6x | 584.1x | 2.4x |
| Fri, 22 Aug 2025 | SEK 35.0b | SEK 14.7b | SEK 59.9m | 56.2x | 583.4x | 2.4x |
| Sun, 20 Jul 2025 | SEK 46.1b | SEK 16.7b | SEK 444.3m | 63.1x | 103.8x | 2.8x |
| Tue, 17 Jun 2025 | SEK 47.2b | SEK 16.6b | SEK 404.2m | 69x | 116.8x | 2.8x |
| Thu, 15 May 2025 | SEK 46.1b | SEK 16.6b | SEK 415.3m | 46.4x | 111x | 2.8x |
| Sat, 12 Apr 2025 | SEK 34.9b | SEK 16.6b | SEK 609.4m | 36.9x | 57.3x | 2.1x |
| Mon, 10 Mar 2025 | SEK 38.5b | SEK 16.6b | SEK 614.9m | 39.2x | 62.5x | 2.3x |
| Wed, 05 Feb 2025 | SEK 40.6b | SEK 16.8b | -SEK 1,173,511,426.00 | 43.6x | -34.6x | 2.4x |
| Fri, 03 Jan 2025 | SEK 44.5b | SEK 16.7b | -SEK 1,152,911,426.00 | 50.6x | -38.6x | 2.7x |
| Sun, 01 Dec 2024 | SEK 41.9b | SEK 16.7b | -SEK 1,154,323,426.00 | 47.4x | -36.3x | 2.5x |
| Tue, 29 Oct 2024 | SEK 44.2b | SEK 16.8b | -SEK 956,465,491.00 | 51.7x | -46.2x | 2.6x |
| Thu, 26 Sep 2024 | SEK 46.8b | SEK 16.7b | -SEK 988,175,491.00 | 57.5x | -47.3x | 2.8x |
| Sat, 24 Aug 2024 | SEK 48.7b | SEK 16.7b | -SEK 985,000,538.00 | 61.2x | -49.5x | 2.9x |
| Mon, 22 Jul 2024 | SEK 48.6b | SEK 16.6b | -SEK 1,138,220,510.00 | 61.7x | -42.7x | 2.9x |
| Wed, 19 Jun 2024 | SEK 43.3b | SEK 16.3b | -SEK 1,188,686,510.00 | 58x | -36.5x | 2.7x |
| Fri, 17 May 2024 | SEK 42.1b | SEK 16.3b | -SEK 1,157,635,671.00 | 36.7x | -36.4x | 2.6x |
| Sun, 14 Apr 2024 | SEK 38.5b | SEK 16.0b | -SEK 1,122,792,213.00 | 35.5x | -34.3x | 2.4x |
| Tue, 12 Mar 2024 | SEK 40.3b | SEK 16.0b | -SEK 1,123,139,210.00 | 42.2x | -35.9x | 2.5x |
| Thu, 08 Feb 2024 | SEK 39.7b | SEK 15.8b | -SEK 1,473,823,683.00 | 56.5x | -26.9x | 2.5x |
| Sat, 06 Jan 2024 | SEK 35.9b | SEK 15.5b | -SEK 1,393,723,683.00 | 43.5x | -25.8x | 2.3x |
| Mon, 04 Dec 2023 | SEK 34.6b | SEK 15.5b | -SEK 1,393,723,683.00 | 40.6x | -24.8x | 2.2x |
| Wed, 01 Nov 2023 | SEK 28.3b | SEK 15.4b | -SEK 1,255,923,711.00 | 32x | -22.5x | 1.8x |
| Fri, 29 Sep 2023 | SEK 26.3b | SEK 15.1b | -SEK 1,134,516,711.00 | 39.1x | -23.2x | 1.7x |
| Sun, 27 Aug 2023 | SEK 30.1b | SEK 15.1b | -SEK 1,137,904,038.00 | 41.6x | -26.4x | 2x |
| Tue, 25 Jul 2023 | SEK 32.7b | SEK 14.9b | -SEK 239,671,038.00 | 46.7x | -136.5x | 2.2x |
| Thu, 22 Jun 2023 | SEK 35.8b | SEK 14.6b | -SEK 172,476,038.00 | 38.7x | -207.7x | 2.4x |
-207.7x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 0.46% | |
| Healthcare | 0.38% | |
| Life Sciences | 0.53% | |
| Clinical Research and Equipment | 0.53% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | SEK 160.80 | 2.0% +SEK 377.8m | -19.0% | PE34.5x | |
| GENO Genovis AB (publ.) | SEK 19.58 | 0.9% +SEK 11.9m | -26.5% | PE53.2x |